Nvidia (NASDAQ: NVDA) Stock Rating: Stop After Q3 FY1/27 Earnings
Nvidia reported $115.8 billion in Q3 revenue, up 103%, and guided $130 billion, while Jensen Huang’s resignation left Colette Kress as interim CEO.
Nvidia reported $115.8 billion in Q3 revenue, up 103%, and guided $130 billion, while Jensen Huang’s resignation left Colette Kress as interim CEO.
@akramsrazor Ultimately, over a 2 to 3 year window, there are: too many GPU/ASIC-TPU suppliers; demand is not sustainable; and there is too much price competition (in the form of loans, gaurantees, and warrants) = thus, they’re all shorts $AMD $AVGO $NVDA
Doesn’t seem like this story is going to die easily. How long until $NVDA’s GC is running the show?
To be honest though, I have successfully short $COST twice in the past, it’s just terribly low beta so even if you time it right it’s a slow trade
CNBC headline: "Nvidia interim CEO Kress talks exclusively to CNBC’s Jim Cramer". Oh no. $NVDA
Century Aluminum (CENX) could benefit from U.S. tariffs, Midwest aluminum premiums and constrained global supply, with the stock trading…
Figma grew Q3 revenue 43% to $391.4 million, raised FY2026 guidance to nearly $1.5 billion and guided Q4 above consensus despite the stock…
CDW CEO Chris Leahy says AI adoption has reached a make-or-break phase as customers seek trusted guidance amid proliferating IT choices.
Realty Income trades near $58, with 2026 AFFO guidance of $4.45 to $4.46 per share and a 5.5% dividend yield supported by a low-70% payout…
Alphabet’s Google Cloud, Gemini training costs and capex shape the company’s valuation as cloud becomes a larger earnings driver.
Perpetua Resources’ permitted Stibnite project holds 4.8 million gold ounces and a $2.9 billion EXIM loan, but faces single-asset…
S&P Global’s valuation swung from 7x earnings in 2009 to 50x in 2024 as ratings, indices and proprietary data expanded through acquisitions…
Amneal Pharmaceuticals posted its fourth straight earnings beat, with Q3 revenue up 10%, raised FY26 guidance and an expanding biosimilar…
Monte Investments rotated Nvidia into Alphabet before earnings and reviews Knife River’s margin squeeze, AMD’s World Labs acquisition, and…
Elanco’s earnings inflection and prospective dividend support targeted low-double-digit EPS growth despite Zoetis discounting.
UTI · long Universal Technical Institute’s selloff creates a valuation case tied to long-term demand for skilled trade labor in the U.S.
Intel's Q3 2026 results were hit by memory costs and an Israel shutdown, but enterprise AI inference could lift CPU demand as server…
Twist Bioscience’s $200 rebound followed an Anthropic-linked short squeeze, yet its DNA and protein services face broad competition while…
Vishay reported record Q3 revenue of $979 million, up 24%, and guided Q4 to about $990 million as rising backlog and margins contrast with…
AutoNation, Lear, NexPoint, AudioCodes and Xponential Fitness lead a 52-situation screen spanning buybacks, insider purchases, M&A and…
Telkom Indonesia trades at 9x earnings and an 11% yield as MSCI-driven selling obscures telecom consolidation, price increases and…
Florida marinas are 92% full as boat counts rise and permits constrain new supply, creating pricing power for existing operators such as…
EToro trades at 2.89x EV/FCF with $304 million in trailing free cash flow, expanding from crypto into equities, commodities, currencies and…
Microsoft rose 6.7% to a $555.80 record after Q1 FY27, with profitable growth and free cash flow reinforcing investor confidence in its AI…
Moderna’s Phase 3 melanoma regimen cut relapse or death 42%, but persistent cash burn and limited launches leave its $220.83 share price…
Every publication on this site, hand-picked.
Every account on this site, hand-picked.
Ordered by how often our editor reaches for them.